Chairman Lee Yang-gu of Dong Sung Pharmaceuticals has filed for a provisional injunction to suspend the duties of CEO Na Won-kyun and directors Won Yong-min and Namgung Kwang. This move comes after a lawsuit was filed to prevent the listing of new shares, which was feared to dilute Chairman Lee’s shareholding. In response, the company stated it plans to actively respond through legal procedures.
Original Article: Read More
Auto-posted at: 2025-05-13 21:05:13